Trademark: 88686147
Word
PACT PHARMA
Status
Dead
Status Code
711
Status Date
Tuesday, November 14, 2023
Serial Number
88686147
Registration Number
6503027
Registration Date
Tuesday, September 28, 2021
Mark Type
4000
Filing Date
Saturday, November 9, 2019
Published for Opposition
Tuesday, June 1, 2021
Cancellation Date
Tuesday, November 14, 2023

Trademark Owner History
PACT Pharma, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
"PHARMA"

Trademark Events
Nov 15, 2023
Notice Of Cancellation Sec. 7 Surrender Emailed
Nov 14, 2023
Cancelled Section 7-Total
Jun 16, 2023
Request For Sect 7 Total Surrender Filed
Nov 7, 2023
Case Assigned To Post Registration Paralegal
Nov 7, 2023
Case Assigned To Post Registration Paralegal
Jun 16, 2023
Teas Section 7 Surrender Received
Sep 28, 2021
Registered-Principal Register
Aug 24, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 23, 2021
Allowed Principal Register - Sou Accepted
Aug 23, 2021
Statement Of Use Processing Complete
Aug 18, 2021
Use Amendment Filed
Aug 23, 2021
Case Assigned To Intent To Use Paralegal
Aug 18, 2021
Teas Statement Of Use Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 24, 2021
Approved For Pub - Principal Register
Apr 24, 2021
Examiner's Amendment Entered
Apr 24, 2021
Notification Of Examiners Amendment E-Mailed
Apr 24, 2021
Examiners Amendment E-Mailed
Apr 24, 2021
Examiners Amendment -Written
Apr 22, 2021
Jurisdiction Restored To Examining Attorney
Dec 8, 2020
Reply Brief Filed - Check Ttab Files
Nov 16, 2020
Notification Of Examiners Statement E-Mailed
Nov 16, 2020
Examiners Statement E-Mailed
Nov 16, 2020
Examiners Statement - Completed
Sep 28, 2020
Jurisdiction Restored To Examining Attorney
Aug 31, 2020
Notification Of Action Denying Req For Recon E-Mailed
Aug 31, 2020
Action Denying Req For Recon E-Mailed
Aug 31, 2020
Action Continuing Final - Completed
Aug 29, 2020
Teas/Email Correspondence Entered
Aug 29, 2020
Correspondence Received In Law Office
Aug 27, 2020
Assigned To Lie
Aug 7, 2020
Teas Request For Reconsideration Received
Aug 7, 2020
Ex Parte Appeal-Instituted
Aug 7, 2020
Jurisdiction Restored To Examining Attorney
Aug 7, 2020
Exparte Appeal Received At Ttab
Jul 18, 2020
Notification Of Final Refusal Emailed
Jul 18, 2020
Final Refusal E-Mailed
Jul 18, 2020
Final Refusal Written
Jul 7, 2020
Teas/Email Correspondence Entered
Jul 7, 2020
Correspondence Received In Law Office
Jul 7, 2020
Teas Response To Office Action Received
Feb 20, 2020
Notification Of Non-Final Action E-Mailed
Feb 20, 2020
Non-Final Action E-Mailed
Feb 20, 2020
Non-Final Action Written
Feb 13, 2020
Assigned To Examiner
Nov 16, 2019
New Application Office Supplied Data Entered
Nov 13, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24